New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases

Overview

Journal Nutrients

Date 2023 Nov 14

PMID 37960237

Authors

Baixi Chen

Yuhua Wang

Guangjie Chen

Affiliations

Soon will be listed here.

Abstract

The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is an essential component of the human innate immune system, and is closely associated with adaptive immunity. In most cases, the activation of the NLRP3 inflammasome requires priming and activating, which are influenced by various ion flux signals and regulated by various enzymes. Aberrant functions of intracellular NLRP3 inflammasomes promote the occurrence and development of autoimmune diseases, with the majority of studies currently focused on rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. In recent years, a number of bioactive substances have shown new potentiality for regulating the NLRP3 inflammasome in autoimmune diseases. This review provides a concise overview of the composition, functions, and regulation of the NLRP3 inflammasome. Additionally, we focus on the newly discovered bioactive substances for regulating the NLRP3 inflammasome in autoimmune diseases in the past three years.

Citing Articles

Ro60-Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases.

Mahla R, Jones E, Dustin L Int J Mol Sci. 2024; 25(14).

PMID: 39062948 PMC: 11277228. DOI: 10.3390/ijms25147705.

Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis?.

Sircana M, Erre G, Castagna F, Manetti R Life (Basel). 2024; 14(6).

PMID: 38929699 PMC: 11204900. DOI: 10.3390/life14060716.

Inflammasome Molecular Insights in Autoimmune Diseases.

Neamtu M, Bild V, Vasincu A, Arcan O, Bulea D, Ababei D Curr Issues Mol Biol. 2024; 46(4):3502-3532.

PMID: 38666950 PMC: 11048795. DOI: 10.3390/cimb46040220.

Pathogenic Mechanisms and Therapeutic Approaches in Obesity-Related Knee Osteoarthritis.

Shumnalieva R, Kotov G, Ermencheva P, Monov S Biomedicines. 2024; 12(1).

PMID: 38275369 PMC: 10812969. DOI: 10.3390/biomedicines12010009.

References

Ali M, Dasari H, Van Keulen V, Carmona E . Canonical Stimulation of the NLRP3 Inflammasome by Fungal Antigens Links Innate and Adaptive B-Lymphocyte Responses by Modulating IL-1β and IgM Production. Front Immunol. 2017; 8:1504. PMC: 5684107. DOI: 10.3389/fimmu.2017.01504. View

Su J, Tao Y, Liu J, Sun J, Zeng Y, Meng X . Tibetan medicine Qi-Sai-Er-Sang-Dang-Song Decoction inhibits TNF-α-induced rheumatoid arthritis in human fibroblast-like synoviocytes via regulating NOTCH1/NF-κB/NLRP3 pathway. J Ethnopharmacol. 2023; 310:116402. DOI: 10.1016/j.jep.2023.116402. View

Palazon-Riquelme P, Worboys J, Green J, Valera A, Martin-Sanchez F, Pellegrini C . USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018; 19(10). PMC: 6172458. DOI: 10.15252/embr.201744766. View

Taatjes D . The Continuing SAGA of TFIID and RNA Polymerase II Transcription. Mol Cell. 2017; 68(1):1-2. DOI: 10.1016/j.molcel.2017.09.028. View

Choi S, Kim T . Compound K - An immunomodulator of macrophages in inflammation. Life Sci. 2023; 323:121700. DOI: 10.1016/j.lfs.2023.121700. View

Bittner Z, Liu X, Mateo Tortola M, Tapia-Abellan A, Shankar S, Andreeva L . BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity. J Exp Med. 2021; 218(11). PMC: 8480672. DOI: 10.1084/jem.20201656. View

Han X, Zhang X, Song R, Li S, Zou S, Tan Q . Necrostatin-1 Alleviates Diffuse Pulmonary Haemorrhage by Preventing the Release of NETs via Inhibiting NE/GSDMD Activation in Murine Lupus. J Immunol Res. 2023; 2023:4743975. PMC: 9995194. DOI: 10.1155/2023/4743975. View

Guo X, Chen G . Hypoxia-Inducible Factor Is Critical for Pathogenesis and Regulation of Immune Cell Functions in Rheumatoid Arthritis. Front Immunol. 2020; 11:1668. PMC: 7399093. DOI: 10.3389/fimmu.2020.01668. View

Li C, Yin W, Yu N, Zhang D, Zhao H, Liu J . miR-155 promotes macrophage pyroptosis induced by Porphyromonas gingivalis through regulating the NLRP3 inflammasome. Oral Dis. 2019; 25(8):2030-2039. DOI: 10.1111/odi.13198. View

10.

Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin X . New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018; 560(7717):198-203. PMC: 6329306. DOI: 10.1038/s41586-018-0372-z. View

11.

Kahlenberg J, Carmona-Rivera C, Smith C, Kaplan M . Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol. 2012; 190(3):1217-26. PMC: 3552129. DOI: 10.4049/jimmunol.1202388. View

12.

Zhang F, Wei K, Slowikowski K, Fonseka C, Rao D, Kelly S . Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019; 20(7):928-942. PMC: 6602051. DOI: 10.1038/s41590-019-0378-1. View

13.

Cutolo M, Soldano S, Smith V . Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol. 2019; 15(7):753-764. DOI: 10.1080/1744666X.2019.1614915. View

14.

Xu Y, Biby S, Kaur B, Zhang S . A patent review of NLRP3 inhibitors to treat autoimmune diseases. Expert Opin Ther Pat. 2023; 33(6):455-470. PMC: 10440821. DOI: 10.1080/13543776.2023.2239502. View

15.

Wang L, Wang F, Gershwin M . Human autoimmune diseases: a comprehensive update. J Intern Med. 2015; 278(4):369-95. DOI: 10.1111/joim.12395. View

16.

Shin M, Kang Y, Lee N, Wahl E, Kim S, Kang K . Self double-stranded (ds)DNA induces IL-1β production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies. J Immunol. 2013; 190(4):1407-15. PMC: 3563755. DOI: 10.4049/jimmunol.1201195. View

17.

Watanabe H, Mokuda S, Tokunaga T, Kohno H, Ishitoku M, Araki K . Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signaling. Inflamm Regen. 2023; 43(1):2. PMC: 9817275. DOI: 10.1186/s41232-022-00252-4. View

18.

Lasithiotaki I, Giannarakis I, Tsitoura E, Samara K, Margaritopoulos G, Choulaki C . NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung. Eur Respir J. 2016; 47(3):910-8. DOI: 10.1183/13993003.00564-2015. View

19.

Mao X, Wu W, Nan Y, Sun W, Wang Y . SMAD2 inhibits pyroptosis of fibroblast-like synoviocytes and secretion of inflammatory factors via the TGF-β pathway in rheumatoid arthritis. Arthritis Res Ther. 2023; 25(1):144. PMC: 10410963. DOI: 10.1186/s13075-023-03136-1. View

20.

Tian J, Zhou D, Xiang L, Liu X, Zhang H, Wang B . MiR-223-3p inhibits inflammation and pyroptosis in monosodium urate-induced rats and fibroblast-like synoviocytes by targeting NLRP3. Clin Exp Immunol. 2021; 204(3):396-410. PMC: 8119838. DOI: 10.1111/cei.13587. View